KYMR logo

Kymera Therapeutics (KYMR) Cash From Investing

Annual CFI

$139.89 M
+$119.37 M+581.74%

December 31, 2023


Summary


Performance

KYMR Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKYMRcash flowmetrics:

Quarterly CFI

-$157.68 M
-$173.32 M-1108.06%

September 30, 2024


Summary


Performance

KYMR Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKYMRcash flowmetrics:

TTM CFI

-$453.69 M
-$218.19 M-92.65%

September 30, 2024


Summary


Performance

KYMR TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKYMRcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

KYMR Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+581.7%-932.0%-424.3%
3 y3 years+133.1%-932.0%-424.3%
5 y5 years+10000.0%-932.0%-424.3%

KYMR Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+240.1%-292.8%+52.3%-424.3%at low
5 y5-yearat high+133.1%-292.8%+52.8%-424.3%at low
alltimeall timeat high+133.1%-292.8%+52.8%-424.3%at low

Kymera Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$157.68 M(-1108.1%)
-$453.69 M(+92.6%)
Jun 2024
-
$15.64 M(-104.7%)
-$235.50 M(+9.4%)
Mar 2024
-
-$330.61 M(-1844.4%)
-$215.31 M(-253.9%)
Dec 2023
$139.89 M(+581.7%)
$18.95 M(-68.7%)
$139.89 M(+96.3%)
Sep 2023
-
$60.51 M(+68.8%)
$71.27 M(-366.7%)
Jun 2023
-
$35.84 M(+45.8%)
-$26.72 M(-238.9%)
Mar 2023
-
$24.58 M(-149.5%)
$19.24 M(-6.2%)
Dec 2022
$20.52 M
-$49.67 M(+32.5%)
$20.52 M(+847.3%)
Sep 2022
-
-$37.48 M(-145.8%)
$2.17 M(-102.2%)
Jun 2022
-
$81.80 M(+216.3%)
-$97.22 M(-17.8%)
DateAnnualQuarterlyTTM
Mar 2022
-
$25.86 M(-138.0%)
-$118.30 M(+18.5%)
Dec 2021
-$99.83 M(-76.4%)
-$68.02 M(-50.3%)
-$99.83 M(+178.8%)
Sep 2021
-
-$136.86 M(-325.4%)
-$35.81 M(-84.7%)
Jun 2021
-
$60.72 M(+37.0%)
-$233.26 M(-31.6%)
Mar 2021
-
$44.32 M(-1210.9%)
-$340.86 M(-19.3%)
Dec 2020
-$422.59 M(+2463.3%)
-$3.99 M(-98.8%)
-$422.59 M(+1.0%)
Sep 2020
-
-$334.32 M(+613.2%)
-$418.60 M(+396.7%)
Jun 2020
-
-$46.87 M(+25.3%)
-$84.28 M(+125.3%)
Mar 2020
-
-$37.40 M
-$37.40 M
Dec 2019
-$16.49 M(+1115.8%)
-
-
Dec 2018
-$1.36 M
-
-

FAQ

  • What is Kymera Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Kymera Therapeutics?
  • What is Kymera Therapeutics annual CFI year-on-year change?
  • What is Kymera Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Kymera Therapeutics?
  • What is Kymera Therapeutics quarterly CFI year-on-year change?
  • What is Kymera Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Kymera Therapeutics?
  • What is Kymera Therapeutics TTM CFI year-on-year change?

What is Kymera Therapeutics annual cash flow from investing activities?

The current annual CFI of KYMR is $139.89 M

What is the all time high annual CFI for Kymera Therapeutics?

Kymera Therapeutics all-time high annual cash flow from investing activities is $139.89 M

What is Kymera Therapeutics annual CFI year-on-year change?

Over the past year, KYMR annual cash flow from investing activities has changed by +$119.37 M (+581.74%)

What is Kymera Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of KYMR is -$157.68 M

What is the all time high quarterly CFI for Kymera Therapeutics?

Kymera Therapeutics all-time high quarterly cash flow from investing activities is $81.80 M

What is Kymera Therapeutics quarterly CFI year-on-year change?

Over the past year, KYMR quarterly cash flow from investing activities has changed by -$176.63 M (-932.00%)

What is Kymera Therapeutics TTM cash flow from investing activities?

The current TTM CFI of KYMR is -$453.69 M

What is the all time high TTM CFI for Kymera Therapeutics?

Kymera Therapeutics all-time high TTM cash flow from investing activities is $139.89 M

What is Kymera Therapeutics TTM CFI year-on-year change?

Over the past year, KYMR TTM cash flow from investing activities has changed by -$593.58 M (-424.33%)